Segerseth Raises 10 Million Yuan in Angel Round Financing

According to PEDaily, Segerseth recently announced the completion of 10-million-yuan angel round financing, led by Shenzhen Aoyin Angel Venture Capital. This round of financing will be mainly used for the research and development of the products, the registration and production, and other aspects.

Founded in 2017, Segerseth focuses on the research and development, manufacturing and sales of minimally invasive medical instruments. Its main products include ultrasonic soft tissue cutting hemostatic system, abdominal puncture apparatus, laparoscopic instruments, absorbable polymer hemostatic clamps and so on. Since its launch, the company has applied for more than 30 domestic and foreign patents, including 20 domestic invention patents, 2 international invention patents and 12 authorized patents.

In recent years, the market of minimally invasive medical surgical instruments is rapidly developing in the Chinese medical instrument industry. Feng Gengchao, the founder of Segerseth, said, "Given that China's minimally invasive medical surgical equipment industry started late, most domestic manufacturers are not strong enough to compete with global leading enterprises in terms of R&D and financial strength. But under the general trend of import substitution, our Chinese medical instrument manufacturers do have a great opportunity.”

To follow the policy, the business model of Segerseth will be transformed from distributing and promoting to providing distributing and academic services, to expand the market and improve its business performance.